Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By



Set Alert for Pharmaceuticals

FDA working with Elanco on tylosin phosphate issues, advises vets on use

The US FDA has issued a letter to veterinarians clarifying the agency's stance on the use of tylosin phosphate in beef cattle.

Elanco Pharmaceuticals

Review 2018: Smart M&A money is put on diagnostics and digital tech

In 2018, the stand-out M&A deals targeted diagnostics, digital technologies and nutrition. While Zoetis and Merck Animal Health made multi-billion-dollar deals, some of the sector's smaller purchases also hinted towards important trends. Animal Pharm editor Joseph Harvey looks back at where the money was spent.

M&A Abaxis

FDA collaborates with Pfizer to alleviate vet opioid shortage

The US FDA is working with Pfizer to alleviate a shortage of specific injectable opioids to treat pain in animals.

United States FDA

Stewardship efforts succeed as US witnesses ongoing decline in sales of antimicrobials

The US FDA has reported a 33% year-on-year drop in domestic sales and distribution of medically important antimicrobials for use in food-producing animals in 2017.

United States FDA

Stonehaven Incubate targets pet antimicrobials in latest project

Stonehaven Incubate has partnered with antimicrobial protein specialist Lysando to develop therapies for companion animal infections. 

R&D Companion Animals

McDonald's announces new targets for restricting antibiotic use in beef

McDonald's has kept a promise it made earlier this year by adopting a policy to reduce the use of medically important antibiotics across 85% of its global beef supply chain.

McDonald’s Bovine

Canadian firm begins pet diabetes SGLT2 inhibitor study for unnamed partner

Sirona Biochem has commenced a proof-of-concept study for its SGLT2 inhibitor as a potential diabetes treatment for cats. 

R&D Pharmaceuticals

ImmuCell receives USDA approval for syringe version of scours preventative

ImmuCell has been issued USDA approval for Dual-Force First Defense.

Pharmaceuticals Bovine

Bayer to develop cryptosporidiosis treatment in ParaTheraTech partnership

Bayer Animal Health is working with US biopharmaceutical firm ParaTheraTech (PTT) to develop a cryptosporidiosis treatment for food-producing animals.

Bayer Animal Health Pharmaceuticals

AdvaVet targets Nasdaq public listing next year

Pet oncology specialist AdvaVet is targeting an initial public offering (IPO) on the Nasdaq Capital Markets next year.

Investments Operations

Virbac calf diarrhea generic gets EU positive opinion

European authorities have given the green light for the approval of Virbac's Kriptazen (halofuginone).

Product Approvals Generics

Boehringer noise aversion treatment approved in US

The US FDA's Center for Veterinary Medicine has approved Boehringer Ingelheim Vetmedica's Pexion (imepitoin tablets) to treat noise aversion in dogs.

Boehringer Ingelheim Animal Health Pharmaceuticals
See All